Evolus Ownership | Who Owns Evolus?
Evolus Ownership Summary
Evolus is owned by 17.29% institutional investors, 10.42% insiders, and 72.28% retail investors. Perceptive advisors is the largest institutional shareholder, holding 8.15% of EOLS shares. BioPharma Credit Ord is the top mutual fund, with 9.10% of its assets in Evolus shares.
EOLS Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Evolus | 17.29% | 10.42% | 72.28% |
| Sector | Healthcare Stocks | 57.39% | 9.93% | 32.68% |
| Industry | Specialty & Generic Drug Manufacturers Stocks | 26.69% | 10.91% | 62.39% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Perceptive advisors | 5.15M | 8.15% | $56.81M |
| Tang capital management | 5.00M | 7.91% | $55.17M |
| Blackrock funding, inc. /de | 4.36M | 6.91% | $48.19M |
| Blackrock | 4.01M | 6.82% | $43.49M |
| Vanguard group | 3.17M | 5.02% | $35.01M |
| Nantahala capital management | 3.13M | 4.96% | $34.56M |
| Caligan partners lp | 2.69M | 4.26% | $29.72M |
| Morgan stanley | 1.48M | 2.52% | $16.07M |
| State street | 1.42M | 2.25% | $15.70M |
| Millennium management | 1.37M | 2.17% | $15.11M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Stonepine capital management | 1.26M | 11.27% | $13.96M |
| Awh capital | 635.00K | 8.34% | $7.01M |
| Caligan partners lp | 2.69M | 7.53% | $29.72M |
| Allostery investments lp | 431.12K | 4.97% | $4.76M |
| Great point partners | 895.52K | 4.66% | $9.89M |
| Tang capital management | 5.00M | 3.65% | $55.17M |
| Altium capital management lp | 685.00K | 2.15% | $7.56M |
| Tri locum partners lp | 742.57K | 1.70% | $8.20M |
| Perceptive advisors | 5.15M | 1.57% | $56.81M |
| Nantahala capital management | 3.13M | 1.48% | $34.56M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Blackrock | 4.01M | 0.00% | 747.40K |
| Tri locum partners lp | 742.57K | 1.70% | 742.57K |
| Gilder gagnon howe | 702.24K | 0.08% | 520.86K |
| Caligan partners lp | 2.69M | 7.53% | 498.90K |
| Ubs group | 1.09M | 0.00% | 448.10K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Morgan stanley | 1.48M | 0.00% | -1.56M |
| Assenagon asset management | 435.45K | 0.01% | -520.10K |
| Lord, abbett | 497.85K | 0.02% | -497.60K |
| Cutter capital management, lp | - | - | -465.30K |
| Armistice capital | - | - | -360.00K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Tri locum partners lp | 742.57K | 1.70% | 742.57K | $8.20M |
| Allostery investments lp | 431.12K | 4.97% | 431.12K | $4.76M |
| Frontier capital management | 239.81K | 0.03% | 239.81K | $2.65M |
| Jefferies financial group | 68.18K | 0.00% | 68.18K | $752.72K |
| Raymond james financial | 52.03K | 0.00% | 52.03K | $574.89K |
Sold Out
| Holder | Change |
|---|---|
| National bank of canada /fi/ | -2.00 |
| Lindbrook capital | -21.00 |
| Signaturefd | -29.00 |
| Geneos wealth management | -36.00 |
| Riggs asset managment | -39.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 51 | -69.82% | 10,920,539 | -78.29% | 17 | 0.27% | 22 | -73.81% | 14 | -68.89% |
| Sep 30, 2024 | 168 | 3.07% | 50,297,352 | -2.04% | 79 | 1.19% | 84 | -14.29% | 45 | 18.42% |
| Jun 30, 2024 | 162 | -5.81% | 51,344,330 | 4.02% | 87 | 1.24% | 97 | 7.78% | 38 | -19.15% |
| Mar 31, 2024 | 172 | 10.26% | 49,361,859 | 8.41% | 83 | 1.31% | 90 | 23.29% | 47 | -11.32% |
| Dec 31, 2023 | 156 | 9.09% | 45,531,650 | 10.19% | 79 | 1.52% | 73 | -12.05% | 53 | 70.97% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| BioPharma Credit Ord | 5.76M | 9.10% | -175.05K |
| Vanguard Total Stock Mkt Idx Inv | 1.69M | 2.67% | 8.10K |
| Vanguard US Total Market Shares ETF | 1.68M | 2.65% | - |
| iShares Russell 2000 ETF | 1.47M | 2.31% | -12.71K |
| Schroder US Smaller Companies Acc | 760.86K | 1.20% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 742.74K | 1.17% | 10.88K |
| Oberweis Micro-Cap | 677.60K | 1.07% | 162.70K |
| Oberweis Micro-Cap Growth | 677.60K | 1.07% | 162.70K |
| Xtrackers S&P 500 Swap ETF 1C | 578.12K | 0.92% | -153.31K |
| CREF Stock R3 | 572.75K | 0.90% | 245.42K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Mar 27, 2025 | MOATAZEDI DAVID | See Remarks | Sell | $77.51K |
| Mar 18, 2025 | Avelar Rui | See Remarks | Sell | $369.87K |
| Mar 18, 2025 | Beaver Sandra | Chief Financial Officer | Sell | $119.24K |
| Mar 18, 2025 | Yamagishi-Dressler Tomoko | Chief Marketing Officer | Sell | $60.12K |
| Mar 18, 2025 | MOATAZEDI DAVID | See Remarks | Sell | $1.37M |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q1 | - | 6 |
| 2024 Q4 | - | 3 |
| 2024 Q3 | - | 2 |
| 2024 Q2 | - | 10 |
| 2024 Q1 | - | 8 |
EOLS Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools